Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Labs that work with it treat the peptide as a tool for generating hypotheses and exploring mechanisms, not as a finished treatment
Published clinical trials have not demonstrated any direct weight loss effect from glutathione supplementation alone
TB-500 (Thymosin Beta-4 Fragment) TB-500 is widely researched for its potential interaction with: Tissue-maintenance and recovery-focused pathways Muscle- and soft-tissue-related signaling Cellular-mobility and regenerative mechanisms Recovery-focused physiological pathways Tissue-remodeling research Research involving TB-500 commonly explores recovery-focused and tissue-maintenance pathways
demonstrated, in addition to higher weight loss in the group treated with high-dose liraglutide 3.0 mg/day for 32 weeks, significant improvements not only of fasting glucose and HOMA-IR, but also of the post-load glucose measured by OGTT, OGTT-derived insulin sensitivity index (SIOGTT), and corrected the early insulin response to a glucose challenge (IGI/HOMA) compared to placebo [62]
